Evidence map›Paper›PMID 34228137›Full record

ReviewDer Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete2021

[Hidradenitis suppurativa /acne inversa-surgical options, reconstruction and combinations with drug therapies-an update].

P Cramer, S Schneider-Burrus, M Kovács, L Scholl, M Podda, F G Bechara

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. [Hidradenitis suppurativa].Dermatologie (Heidelberg, Germany) · 2024
    Article
  3. Review
  4. [Hidradenitis suppurativa/acne inversa: From "orphan disease" to a curable inflammatory skin disorder].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

P CramerKlinik für Dermatologie, Venerologie und Allergologie, Katholisches Klinikum Bochum, St. Josef-Hospital, Klinik der Ruhr-Universität Bochum, Gudrunstr. 56, 44791, Bochum, Deutschland.
S Schneider-BurrusZentrum für Dermatochirurgie, Havelklinik Berlin, Berlin, Deutschland.
M KovácsHautklinik Klinikum Darmstadt - Akademisches Lehrkrankenhaus der Goethe-Universität Frankfurt am Main, Darmstadt, Deutschland.
L SchollKlinik für Dermatologie, Venerologie und Allergologie, Katholisches Klinikum Bochum, St. Josef-Hospital, Klinik der Ruhr-Universität Bochum, Gudrunstr. 56, 44791, Bochum, Deutschland.
M PoddaHautklinik Klinikum Darmstadt - Akademisches Lehrkrankenhaus der Goethe-Universität Frankfurt am Main, Darmstadt, Deutschland.
F G BecharaKlinik für Dermatologie, Venerologie und Allergologie, Katholisches Klinikum Bochum, St. Josef-Hospital, Klinik der Ruhr-Universität Bochum, Gudrunstr. 56, 44791, Bochum, Deutschland. falk.bechara@klinikum-bochum.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hidradenitis suppurativa/acne inversa (HS/AI) is a chronic inflammatory skin disease whose treatment includes both conservative and surgical treatment options. In Hurley stages II and III, surgical resection of irreversibly destroyed tissue should be the objective. For this purpose several resection techniques exist, which differ primarily with regard to their invasiveness and tendency to recur. To date, there is no generally accepted consensus on the use of different resection and reconstruction techniques or the inclusion of drug therapies in the overall therapeutic concept.

Indexed as

DermatitisHidradenitis SuppurativaChronic DiseaseHumansRecurrenceSkinImmunomodulationNegative-pressure wound therapyReconstructive surgical proceduresRecurrence rateWound healing

Identifiers

PMID34228137
PMCPMC8258492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.